Revvity (NYSE:RVTY) Stock Price Up 7.2% – Should You Buy?

Revvity Inc. (NYSE:RVTY) shot up 7.2% during trading on Thursday . The company traded as high as $114.12 and last traded at $113.2620. Approximately 359,431 shares traded hands during trading, a decline of 73% from the average session volume of 1,330,125 shares. The stock had previously closed at $105.63.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. TD Cowen upped their target price on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Robert W. Baird set a $117.00 target price on shares of Revvity in a report on Wednesday, May 6th. Barclays boosted their target price on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Finally, Wolfe Research initiated coverage on Revvity in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $107.73.

Revvity Trading Up 7.7%

The stock has a market capitalization of $12.69 billion, a price-to-earnings ratio of 54.27, a PEG ratio of 2.19 and a beta of 1.11. The company’s 50 day moving average is $96.66 and its 200 day moving average is $97.55. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The company had revenue of $711.12 million for the quarter, compared to analyst estimates of $704.07 million. During the same period last year, the business posted $1.01 EPS. The business’s quarterly revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, research analysts forecast that Revvity Inc. will post 5.25 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s dividend payout ratio (DPR) is 13.40%.

Hedge Funds Weigh In On Revvity

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in shares of Revvity by 15.2% in the third quarter. JPMorgan Chase & Co. now owns 511,360 shares of the company’s stock valued at $44,821,000 after purchasing an additional 67,662 shares in the last quarter. Tudor Investment Corp ET AL acquired a new stake in Revvity during the third quarter worth $15,128,000. Neuberger Berman Group LLC increased its holdings in Revvity by 4,598.9% in the 3rd quarter. Neuberger Berman Group LLC now owns 460,447 shares of the company’s stock valued at $40,358,000 after buying an additional 450,648 shares during the period. Elo Mutual Pension Insurance Co increased its holdings in Revvity by 46.2% in the 3rd quarter. Elo Mutual Pension Insurance Co now owns 19,199 shares of the company’s stock valued at $1,683,000 after buying an additional 6,066 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its stake in shares of Revvity by 127.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after buying an additional 980,142 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.